Profusa has reached a $100 million financing协议, with net proceeds fully used to purchase Bitcoin.

On July 21, 【Block Rhythm】 reported that the commercial phase digital health company Profusa (NASDAQ: PFSA) today announced that it has entered into a securities purchase agreement (equity credit agreement) with Ascent Partners Fund LLC (referred to as "Ascent"), aiming to raise up to $100 million through the issuance of common stock, with the net proceeds fully allocated for the purchase of Bitcoin (for debt repayment), provided that the company's cash balance at the time of the equity sale exceeds $5 million.

According to the terms of the protocol, Profusa has the right to sell common stock to Ascent at a price equal to 97% of the volume-weighted average price (VWAP) over the lowest trading volume within 5 trading days following each sale. The single sale limit is $5 million or 100% of the average daily trading volume over the 5 trading days prior to the sale, whichever is lower. If the company's cash balance falls below $5 million, the net proceeds will first be used to make up that amount, with the remaining funds allocated to Bitcoin as a core reserve asset.